secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0001615219-25-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharmaceuticals files prospectus supplement for ATM offering of up to $417,000
--------------------------------------------------------------------------------

- Filed prospectus supplement on March 10, 2025 for at-the-market offering of up to $417,000 of common stock.
- Offering conducted through Ladenburg Thalmann & Co. under existing S-3 registration statement (333-266589).
- Legal opinion from Hogan Lovells US LLP included as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000033/0001615219-25-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000033/flks-20250310.htm
  HTML page:      https://secwatch.observer/filing/0001615219-25-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer